The synergistic impact of probiotics and dietary fiber on constipation management in chlorpromazine-induced schizophrenia patients: exploring the modulation of intestinal microbiota and neurotrophic factors

References

• Yang WU, Yong-Hua CAO, Yi Z. Efficacy of olanzapine combined with modified electroconvulsive therapy in the treatment of first-episode schizophrenia and its influence on levels of serum inflammatory factors and BDNF,S100B and GFAP. J Clin Exp Med. 2021;20(17):1891–1894. doi: 10.3969/j.issn.1671-4695.2021.17.029.
   Google Scholar
• Xulan S, Rongrong Z, Xiaohui P, et al. Attention disorder and white matter structure changes in schizophrenia. Chin J Behav Me Brain Sci. 2021;30(9):844–849. doi: 10.3760/cma.j.cn371468-20210515-00261.
   Google Scholar
• Kanchanatawan B, Sriswasdi S, Thika S, et al. Deficit schizophrenia is a discrete diagnostic category ­defined by neuro-immune and neurocognitive ­features: results of supervised machine learning. Metab Brain Dis. 2018;33(4):1053–1067. doi: 10.1007/s11011-018-0208-4.
   PubMed Web of Science ®Google Scholar
• Jingnan G, Lijun C, Wei C, et al. Effect of olanzapine, risperidone and quetiapine on glucose and lipid metabolism and sex hormone levels in elderly patients with schizophrenia. Chin Gerontol. 2019;39(24):6046–6048. doi: 10.3969/j.issn.1005-9202.2019.24.047.
   Google Scholar
• Ya J, Yurong T, Chen X, et al. Impact of sleep disorders and related anxiety and depression on 126 patients with chronic constipation. Chin J Dig. 2016;36(5):331–336.
   Google Scholar
• Miaomiao S, Yue X, Xinyu F, et al. The incidence and risk factors of constipation caused by antipsychotic drugs in long-term hospitalized patients with schizophrenia. Chin J Clin Res. 2020;33(11):1502–1506.
   Google Scholar
• Palmer SE, McLean RM, Ellis PM, et al. Life threatening clozapine induced gastrointestinal hypomotility: an analysis of 102 cases. J Clin Psychiatry. 2008;69(5):759–768. doi: 10.4088/jcp.v69n0509.
   PubMed Web of Science ®Google Scholar
• Chen T, Xu H, Sun H. Advance of the improvement effect of dietary fiber on intestinal motility disorders. J Parenter Enteral Nutr. 2017;24(2):122–126.
   Google Scholar
• Zhou S-Y, Liu T, Qin H-Z, et al. Characteristics of commonly used scales for diagnosis and treatment outcome evaluation in constipation. WCJD. 2013;21(25):2611–2616. doi: 10.11569/wcjd.v21.i25.2611.
   Google Scholar
• Hu X, Li W, Qing Z. Probiotics in the treatment of functional constipation in different age groups: research progress. Chin J Microecol. 2020;32(11):1341–1345.
   Google Scholar
• Zhang M, Wang B, Zhou C, et al. Application of probiotics combined with soluble dietary fiber inmiddle-aged and elderly patients with chronic constipation. Chin J Gastroenterol. 2019;24(2):95–98.
   Google Scholar
• Wei W, Li X, Fei G. The effects of dietary fiber on symptoms of functional constipation. Chin J Intern Med. 2019;58(11):845–848.
   PubMedGoogle Scholar
• Yunfei D, Zeping X. Comparison of chinese classification and diagnostic standards for mental disorders version 3 and version 10 of the international classification of diseases. J Clin Psychiatry. 2013;23(6):426–427.
   Google Scholar
• Guidelines for the diagnosis and treatment of chronic constipation in China (2013, Wuhan). Chin J Gastroenterol. 2013;18(10):605–612.
   Google Scholar
• Hou Y, Youran L, Hao W, et al. Efficacy and safety of high dose white atractylodes combined with fructus aurantii immaturus in treatment of functional constipation. WCJD. 2015;23(4):694–700. doi: 10.11569/wcjd.v23.i4.694.
   Google Scholar
• Fang L, Xianpeng W, Xuegui T. Clinical efficacy of modified Zhishi Daozhiwan on slow transit constipation. Chin J Exp Tradit Med Formul. 2020;26(2):92–97.
   Google Scholar
• Zhang Q-G, Yang X-F, Wang H-h Clinical effect addition and subtraction therapy of Si junzitang combined with simotang to outlet obstructive constipation after stapled trans-anal rectal resection. Chin J Expl Tradit MedFormul. 2020;26(19):183–188.
   Google Scholar
• Yuzhen W. Study on constipation-causing factors and intervention countermeasures of antipsychotic drugs. J North Pharmacy. 2022;19(1):63–6569.
   Google Scholar
• Liqun L, Yuanhui Z, Suifeng X, et al. Investigation and analysis of constipation status and related influencing factors in hospitalized schizophrenia patients. Chin Pract Med. 2020;15(7):114–116.
   PubMedGoogle Scholar
• Jauhar S, Johnstone M, Mckenna PJ. Schizophrenia. Lancet. 2022;399(10323):473–486. doi: 10.1016/S0140-6736(21)01730-X.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Yu YB. Intestinal microbiota and chronic constipation. Springerplus. 2016;5(1):1130. doi: 10.1186/s40064-016-2821-1.
   PubMedGoogle Scholar
• Tomizawa Y, Kurokawa S, Ishii D, et al. Effects of psychotropics on the microbiome in patients with depression and anxiety: considerations in a naturalistic clinical setting. Int J Neuropsychopharmacol. 2021;24(2):97–107. doi: 10.1093/ijnp/pyaa070.
   PubMed Web of Science ®Google Scholar
• Ait Chait Y, Mottawea W, Tompkins TA, et al. Evidence of the dysbiotic effect of psychotropics on gut microbiota and capacity of probiotics to alleviate related dysbiosis in a model of the human Colon. Int J Mol Sci. 2023;24(8):7326. doi: 10.3390/ijms24087326.
   PubMed Web of Science ®Google Scholar
• Yoon JY, Cha JM, Oh JK, et al. Probiotics ameliorate stool consistency in patients with chronic constipation: a randomized, double-blind, placebo-controlled study. Dig Dis Sci. 2018;63(10):2754–2764. doi: 10.1007/s10620-018-5139-8.
   PubMed Web of Science ®Google Scholar
• Gordon M, Wallace C, Stone J, et al. Probiotics for treatment of chronic constipation in children: a cochrane systematic review . Gastroenterology. 2016;150(4):S841. doi: 10.1016/S0016-5085(16)32843-8.
   Web of Science ®Google Scholar